---
schema_version: "secwatch.filing_event.v1"
accession: "0000927653-22-000074"
form_type: "8-K"
ticker: "MCK"
cik: "0000927653"
company_name: "MCKESSON CORP"
filed_at: "2022-08-03T23:59:59+00:00"
generated_at: "2026-06-24T05:37:46.745361+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# McKesson Q1 adj EPS $5.83, revenue $67.2B; raises FY2023 outlook to $23.95-$24.65

## Summary
- Adjusted EPS $5.83 vs $5.56 (+5%); GAAP EPS $5.25 vs $3.09 (+70%).
- Revenue $67.2B, up 7% YoY, driven by U.S. pharmaceutical and specialty distribution.
- FY2023 adjusted EPS guidance raised to $23.95-$24.65 from $22.90-$23.60.
- Core adjusted EPS growth (ex-COVID programs) forecasted at 10-15% for fiscal 2023.
- Guidance includes COVID vaccine distribution contribution of $0.35-$0.45 and ancillary supplies/testing of $0.75-$0.95 per share.

## SEC filing metadata
- accession: 0000927653-22-000074
- form_type: 8-K
- ticker: MCK
- cik: 0000927653
- company_name: MCKESSON CORP
- filed_at: 2022-08-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/927653/000092765322000074/0000927653-22-000074-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/927653/000092765322000074/mck-20220803.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000927653-22-000074
- JSON: https://secwatch.observer/filing/0000927653-22-000074.json
- Plain text: https://secwatch.observer/filing/0000927653-22-000074.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.